These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30844798)

  • 1. Chenodeoxycholic Acid Releases Proinflammatory Cytokines from Small Intestinal Epithelial Cells Through the Farnesoid X Receptor.
    Horikawa T; Oshima T; Li M; Kitayama Y; Eda H; Nakamura K; Tamura A; Ogawa T; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Tomita T; Fukui H; Watari J; Miwa H
    Digestion; 2019; 100(4):286-294. PubMed ID: 30844798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages.
    Cao S; Meng X; Li Y; Sun L; Jiang L; Xuan H; Chen X
    Front Immunol; 2021; 12():632864. PubMed ID: 33968024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chenodeoxycholic Acid (CDCA) Protects against the Lipopolysaccharide-Induced Impairment of the Intestinal Epithelial Barrier Function via the FXR-MLCK Pathway.
    Song M; Ye J; Zhang F; Su H; Yang X; He H; Liu F; Zhu X; Wang L; Gao P; Shu G; Jiang Q; Wang S
    J Agric Food Chem; 2019 Aug; 67(32):8868-8874. PubMed ID: 31319027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
    Gadaleta RM; van Erpecum KJ; Oldenburg B; Willemsen EC; Renooij W; Murzilli S; Klomp LW; Siersema PD; Schipper ME; Danese S; Penna G; Laverny G; Adorini L; Moschetta A; van Mil SW
    Gut; 2011 Apr; 60(4):463-72. PubMed ID: 21242261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chenodeoxycholic acid-mediated activation of the farnesoid X receptor negatively regulates hydroxysteroid sulfotransferase.
    Miyata M; Matsuda Y; Tsuchiya H; Kitada H; Akase T; Shimada M; Nagata K; Gonzalez FJ; Yamazoe Y
    Drug Metab Pharmacokinet; 2006 Aug; 21(4):315-23. PubMed ID: 16946559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chenodeoxycholic Acid Reduces Hypoxia Inducible Factor-1α Protein and Its Target Genes.
    Moon Y; Choi SM; Chang S; Park B; Lee S; Lee MO; Choi HS; Park H
    PLoS One; 2015; 10(6):e0130911. PubMed ID: 26098428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone.
    Wang S; Lai K; Moy FJ; Bhat A; Hartman HB; Evans MJ
    Endocrinology; 2006 Sep; 147(9):4025-33. PubMed ID: 16675527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts.
    Id Boufker H; Lagneaux L; Fayyad-Kazan H; Badran B; Najar M; Wiedig M; Ghanem G; Laurent G; Body JJ; Journé F
    Bone; 2011 Dec; 49(6):1219-31. PubMed ID: 21893226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphologic Damage of Rat Alveolar Epithelial Type II Cells Induced by Bile Acids Could Be Ameliorated by Farnesoid X Receptor Inhibitor Z-Guggulsterone In Vitro.
    Wang J; Huang Y; Hou X; Wu W; Nie L; Tian Y; Lu Y; Yin Y
    Biomed Res Int; 2016; 2016():9283204. PubMed ID: 27340672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene.
    Owsley E; Chiang JY
    Biochem Biophys Res Commun; 2003 Apr; 304(1):191-5. PubMed ID: 12705905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
    Bennet SM; Polster A; Törnblom H; Isaksson S; Capronnier S; Tessier A; Le Nevé B; Simrén M; Öhman L
    Am J Gastroenterol; 2016 Aug; 111(8):1165-76. PubMed ID: 27272011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor enhances epithelial ACE2 expression and inhibits virally induced IL-6 secretion: implications for intestinal symptoms of SARS-CoV-2.
    Smyth JS; Truong JK; Rao A; Lin R; Foulke-Abel J; Adorini L; Donowitz M; Dawson PA; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2023 Nov; 325(5):G446-G452. PubMed ID: 37697930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.
    Capello A; Moons LM; Van de Winkel A; Siersema PD; van Dekken H; Kuipers EJ; Kusters JG
    Am J Gastroenterol; 2008 Jun; 103(6):1510-6. PubMed ID: 18510604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ileal bile acid-binding protein expression in Caco-2 cells by ursodeoxycholic acid: role of the farnesoid X receptor.
    Campana G; Pasini P; Roda A; Spampinato S
    Biochem Pharmacol; 2005 Jun; 69(12):1755-63. PubMed ID: 15935148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.
    van Schaik FD; Gadaleta RM; Schaap FG; van Mil SW; Siersema PD; Oldenburg B; van Erpecum KJ
    PLoS One; 2012; 7(11):e49706. PubMed ID: 23189156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.
    Neimark E; Chen F; Li X; Shneider BL
    Hepatology; 2004 Jul; 40(1):149-56. PubMed ID: 15239098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.
    Xu X; Lu Y; Chen L; Chen J; Luo X; Shen X
    Steroids; 2013 Sep; 78(9):813-22. PubMed ID: 23707573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.
    Li WT; Luo QQ; Wang B; Chen X; Yan XJ; Qiu HY; Chen SL
    FASEB J; 2019 Feb; 33(2):2435-2450. PubMed ID: 30260705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.